| Literature DB >> 32289855 |
Enrique Rodríguez-de-Santiago1, Leonardo Frazzoni2, Lorenzo Fuccio2, Jeanin E van Hooft3, Thierry Ponchon4, Cesare Hassan5, Mário Dinis-Ribeiro6,7.
Abstract
With the aim of reducing the overall burden of care, ESGE recommends against surveillance of a series of conditions. Namely: ESGE RECOMMENDS: against surveillance of individuals with the following: an inlet esophageal patch; Los Angeles (LA) grade A or B erosive esophagitis; or < 1 cm columnar-lined esophagus. ESGE RECOMMENDS: against surveillance of those with intestinal metaplasia limited to the antrum unless additional risk factors are present, such as persistent Helicobacter pylori infection, incomplete metaplasia, or a family history of gastric cancer; or for fundic gland polyps in the absence of suspicious endoscopic features or hereditary syndromes. ESGE RECOMMENDS: against surveillance of gastrointestinal leiomyomas, lipomas, and antral pancreatic rests, provided that these lesions have typical ultrasonographic features. ESGE RECOMMENDS: against routine endoscopic surveillance in duodenal peptic ulcer, unless symptoms persist despite adequate therapy. ESGE SUGGESTS: against surveillance of confirmed pancreatic serous cystic neoplasms. ESGE RECOMMENDS: against endoscopic surveillance for patients with hyperplastic polyps in the rectosigmoid, with 1 - 4 adenomas < 10 mm with low-grade dysplasia, or with a serrated polyp < 10 mm without dysplasia. ESGE RECOMMENDS: against surveillance of gastrointestinal conditions in individuals over 80 years old who have less than 10 years of life expectancy and poor general health status. © Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Year: 2020 PMID: 32289855 DOI: 10.1055/a-1137-4721
Source DB: PubMed Journal: Endoscopy ISSN: 0013-726X Impact factor: 10.093